Drug intelligence / Profile preview

MEVAC EDS 76

Development stage
Unknown
Lead developer
MEVAC
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

MEVAC EDS 76 is an inactivated monovalent veterinary vaccine developed by Middle East for Vaccines (MEVAC) to protect poultry against Egg Drop Syndrome (EDS). The vaccine contains inactivated Egg Drop Syndrome '76 virus (avian Atadenovirus) at a concentration of ≥ 8.5 log10 EID50 per dose. It is designed to induce a protective immune response in chickens, breeders, layers, and ducks, specifically preventing the production of soft-shelled and shell-less eggs caused by the virus. The vaccine is formulated as an emulsion that may separate during storage, requiring vigorous shaking before administration to pullets, typically starting from 2 weeks of age and before the onset of lay.

Brand names
MEVAC EDS 76
Other names
Egg Drop Syndrome VaccineEDS 76 VaccineEDS76 VaccineEDS-76 Vaccineegg drop syndrome vaccine-Middle East for Vaccines-veterinary vaccine-Egg Drop Syndrome (Poultry)

Beyond the preview

Go deeper on MEVAC EDS 76.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEVAC EDS 76.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call